BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37540513)

  • 1. Hepatitis C Treatment Initiation Among US Medicaid Enrollees.
    Kapadia SN; Zhang H; Gonzalez CJ; Sen B; Franco R; Hutchings K; Wethington E; Talal A; Lloyd A; Dharia A; Wells M; Bao Y; Shapiro MF
    JAMA Netw Open; 2023 Aug; 6(8):e2327326. PubMed ID: 37540513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.
    Marcus JL; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Lam JO; Pauly MP; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ
    Public Health Rep; 2018; 133(4):452-460. PubMed ID: 29750893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.
    Spradling PR; Xing J; Rupp LB; Moorman AC; Gordon SC; Lu M; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
    J Clin Gastroenterol; 2018 Aug; 52(7):641-647. PubMed ID: 28590325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Access to Hepatitis C Treatment Among Arizona Medicaid Beneficiaries With Chronic Hepatitis C.
    Jiang X; Song HJ; Chang CY; Wilson D; Guo J; Lo-Ciganic WH; Park H
    Med Care; 2023 Feb; 61(2):81-86. PubMed ID: 36453625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs.
    Davey S; Costello K; Russo M; Davies S; Lalani HS; Kesselheim AS; Rome BN
    JAMA Health Forum; 2024 Apr; 5(4):e240302. PubMed ID: 38578628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Cartwright EJ; Pierret C; Minassian C; Esserman DA; Tate JP; Goetz MB; Bhattacharya D; Fiellin DA; Justice AC; Lo Re V; Rentsch CT
    JAMA Netw Open; 2023 Sep; 6(9):e2335715. PubMed ID: 37751206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.
    Kalidindi Y; Jung J; Feldman R; Riley T
    JAMA Netw Open; 2020 Jul; 3(7):e2011055. PubMed ID: 32692371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use.
    Auty SG; Shafer PR; Dusetzina SB; Griffith KN
    JAMA Health Forum; 2021 Aug; 2(8):e212285. PubMed ID: 35977199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of hepatitis C virus treatment in a multi-state Medicaid population, 2013-2017.
    Clements KM; Kunte PS; Clark MA; Gurewich D; Greenwood BC; Sefton L; Pratt C; Person SD; Wessolossky MA
    Health Serv Res; 2022 Dec; 57(6):1312-1320. PubMed ID: 35466398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program.
    Keast SL; Holderread B; Cothran T; Skrepnek GH
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1261-1267. PubMed ID: 31663456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends in Hepatitis C-Related Hospitalizations, United States, 2000-2019.
    Hofmeister MG; Zhong Y; Moorman AC; Samuel CR; Teshale EH; Spradling PR
    Clin Infect Dis; 2023 Dec; 77(12):1668-1675. PubMed ID: 37463305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
    Kanwal F; Kramer JR; El-Serag HB; Frayne S; Clark J; Cao Y; Taylor T; Smith D; White D; Asch SM
    Clin Infect Dis; 2016 Aug; 63(3):291-9. PubMed ID: 27131869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data.
    Mkuu RS; Shenkman EA; Muller KE; Huo T; Salloum RG; Cabrera R; Zarrinpar A; Thomas E; Szurek SM; Nelson DR
    Medicine (Baltimore); 2021 Dec; 100(50):e28316. PubMed ID: 34918711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon.
    Jindai K; Crawford C; Thomas AR
    Public Health Rep; 2019; 134(1):81-88. PubMed ID: 30508493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
    Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?
    Cope R; Glowa T; Faulds S; McMahon D; Prasad R
    AIDS Patient Care STDS; 2016 Feb; 30(2):51-5. PubMed ID: 26744994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C in Black Individuals in the US: A Review.
    Falade-Nwulia O; Kelly SM; Amanor-Boadu S; Nnodum BN; Lim JK; Sulkowski M
    JAMA; 2023 Dec; 330(22):2200-2208. PubMed ID: 37943553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016-2019.
    Ahrens K; Sharbaugh M; Jarlenski MP; Tang L; Allen L; Austin AE; Barnes AJ; Burns ME; Clark S; Zivin K; Mack A; Liu G; Mohamoud S; McDuffie MJ; Hammerslag L; Gordon AJ; Donohue JM;
    Clin Infect Dis; 2023 May; 76(10):1793-1801. PubMed ID: 36594172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
    Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
    Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.
    Ceccarelli L; Moretti G; Mazzilli S; Petri D; Corazza I; Rizzo C; Lucenteforte E; Vainieri M; Seghieri C; Tavoschi L;
    BMC Infect Dis; 2024 Mar; 24(1):362. PubMed ID: 38553731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.